Titre (en)
Analysis
2020
Racine
Analysis
2020
Exploration
Accueil
Racine
Racine

Serveur d'exploration SRAS - Analysis (2020)

Index « Titre (en) » - entrée « drugs »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
drug < drugs < dual  Facettes :

List of bibliographic references

Number of relevant bibliographic references: 17.
Ident.Authors (with country if any)Title
000077 (2020) Mahmoud Kandeel [Égypte] ; Mohammed Al-Nazawi [Arabie saoudite]Virtual screening and repurposing of FDA approved drugs against COVID-19 main protease.
000108 (2020) David CyranoskiThis scientist hopes to test coronavirus drugs on animals in locked-down Wuhan.
000148 (2020) Carlo Perricone [Italie] ; Paola Triggianese [Italie] ; Elena Bartoloni [Italie] ; Giacomo Cafaro [Italie] ; Angelo F. Bonifacio [Italie] ; Roberto Bursi [Italie] ; Roberto Perricone [Italie] ; Roberto Gerli [Italie]The anti-viral facet of anti-rheumatic drugs: Lessons from COVID-19
000186 (2020) Jiayu Liao [États-Unis] ; George Way [États-Unis] ; Vipul Madahar [États-Unis]Target Virus or Target Ourselves for COVID-19 Drugs Discovery?-Lessons learned from anti-influenzas virus therapies.
000187 (2020) Nathan Ford ; Marco Vitoria ; Ajay Rangaraj ; Susan L. Norris ; Alexandra Calmy ; Meg DohertySystematic review of the efficacy and safety of antiretroviral drugs against SARS, MERS or COVID‐19: initial assessment
000286 (2020) Michele Costanzo ; Maria Anna Rachele De Giglio ; Giovanni Nicola RovielloSARS CoV-2: Recent Reports on Antiviral Therapies Based on Lopinavir/Ritonavir, Darunavir/Umifenovir, Hydroxychloroquine, Remdesivir, Favipiravir and Other Drugs for the Treatment of the New Coronavirus.
000383 (2020) Bo Ram Beck [Corée du Sud] ; Bonggun Shin [Corée du Sud, États-Unis] ; Yoonjung Choi [Corée du Sud] ; Sungsoo Park [Corée du Sud] ; Keunsoo Kang [Corée du Sud]Predicting commercially available antiviral drugs that may act on the novel coronavirus (SARS-CoV-2) through a drug-target interaction deep learning model
000469 (2020) Hasanain Abdulhameed Odhar [Iraq] ; Salam Waheed Ahjel [Iraq] ; Ali A. Mohammed Ali Albeer [Iraq] ; Ahmed Fadhil Hashim [Iraq] ; Ali Mahmood Rayshan [Iraq] ; Suhad Sami Humadi [Iraq]Molecular docking and dynamics simulation of FDA approved drugs with the main protease from 2019 novel coronavirus
000474 (2020) Paolo Calligari [Italie] ; Sara Bobone [Italie] ; Giorgio Ricci [Italie] ; Alessio Bocedi [Italie]Molecular Investigation of SARS-CoV-2 Proteins and Their Interactions with Antiviral Drugs.
000560 (2020) Claudia Cava [Italie] ; Gloria Bertoli [Italie] ; Isabella Castiglioni [Italie]In Silico Discovery of Candidate Drugs against Covid-19.
000713 (2020) Shibo JiangDon't rush to deploy COVID-19 vaccines and drugs without sufficient safety guarantees.
000722 (2020) Liying Dong [République populaire de Chine] ; Shasha Hu [République populaire de Chine] ; Jianjun Gao [République populaire de Chine]Discovering drugs to treat coronavirus disease 2019 (COVID-19).
000747 (2020) Md Insiat Islam Rabby [Malaisie]Current Drugs with Potential for Treatment of COVID-19: A Literature Review.
000915 (2020) Mrudula Phadke [Inde] ; Sujata Saunik [Inde]COVID-19 treatment by repurposing drugs until the vaccine is in sight.
000941 (2020) Camillo Sargiacomo [Royaume-Uni] ; Federica Sotgia [Royaume-Uni] ; Michael P. Lisanti [Royaume-Uni]COVID-19 and chronological aging: senolytics and other anti-aging drugs for the treatment or prevention of corona virus infection?
000953 (2020) B. RobsonCOVID-19 Coronavirus spike protein analysis for synthetic vaccines, a peptidomimetic antagonist, and therapeutic drugs, and analysis of a proposed achilles’ heel conserved region to minimize probability of escape mutations and drug resistance
000997 (2020) Canrong Wu [République populaire de Chine] ; Yang Liu [République populaire de Chine] ; Yueying Yang [République populaire de Chine] ; Peng Zhang [République populaire de Chine] ; Wu Zhong [République populaire de Chine] ; Yali Wang [République populaire de Chine] ; Qiqi Wang [République populaire de Chine] ; Yang Xu [République populaire de Chine] ; Mingxue Li [République populaire de Chine] ; Xingzhou Li [République populaire de Chine] ; Mengzhu Zheng [République populaire de Chine] ; Lixia Chen [République populaire de Chine] ; Hua Li [République populaire de Chine]Analysis of therapeutic targets for SARS-CoV-2 and discovery of potential drugs by computational methods

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/SrasV1/Data/2020/Analysis

HfdIndexSelect -h $EXPLOR_AREA/Data/2020/Analysis/Title.i -k "drugs" 

HfdIndexSelect -h $EXPLOR_AREA/Data/2020/Analysis/Title.i  \
                -Sk "drugs" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/2020/Analysis/biblio.hfd

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    SrasV1
   |flux=    2020
   |étape=   Analysis
   |type=    indexItem
   |index=    Title.i
   |clé=    drugs
}}
Wicri

This area was generated with Dilib version V0.6.33.
Data generation: Tue Apr 28 14:49:16 2020. Site generation: Sat Mar 27 22:06:49 2021